← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsEarningsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksMPLTRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

MPLT logoMapLight Therapeutics, Inc. (MPLT) Revenue History

Annual and quarterly revenue from 2022 to 2024

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q3 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

MPLT Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

3 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

MPLT Revenue Analysis (2022–2024)

As of May 15, 2026, MapLight Therapeutics, Inc. (MPLT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.

Looking at the longer-term picture, MPLT's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including ACNB, PTGX (-91.5% YoY), and ACLX (-79.4% YoY). Compare MPLT vs ACNB →

MPLT Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
MPLT logoMPLTCurrent$0---
ACNB logoACNB$170M--27.3%
PTGX logoPTGX$46M-91.5%+10.0%-343.6%
ACLX logoACLX$22M-79.4%--1135.6%
NRXP logoNRXP$1M---1324.4%
Best in groupLowest in group

MPLT Historical Revenue Data (2022–2024)

Showing 3 of 3 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2024$0-$-701,000-$-82,946,000-
2023$0-$-556,000-$-57,282,000-
2022$0-$-574,000-$-31,245,000-

See MPLT's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is MPLT Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare with Peers

Compare business quality, growth, and profitability against top sector peers.

Start Comparison

MPLT — Frequently Asked Questions

Quick answers to the most common questions about buying MPLT stock.

Is MPLT's revenue growth accelerating or slowing?

MPLT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is MPLT's long-term revenue growth rate?

MapLight Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is MPLT's revenue distributed by segment?

MPLT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2024 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Income statements. Balance sheets. Cash flows.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • Earnings Calendar
  • Earnings Today
  • Earnings Hub
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • Value Stocks
  • Quality Compounders
  • Growth Stocks
  • Dividend Stocks
  • Undervalued Stocks
  • Momentum Stocks
  • High Free Cash Flow

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

MPLT Revenue Over Time (2022–2024)